NEWS
Alpha-Stim News and Announcements
New Clinical Review Highlights Alpha-Stim® in Expanding Neuromodulation Landscape MINERAL WELLS, Texas — August 25, 2026 — A new clinical review published in Primary Care Companion for CNS Disorders highlights Alpha-Stim® and cranial electrotherapy stimulation (CES) within the expanding landscape of neuromodulation technologies for central nervous system disorders. The review,
Electromedical Products International, Inc. (EPI), a leader in non-invasive neuromodulation therapeutics, announced it has been awarded a new five-year, $175 million Federal Supply Schedule (FSS) contract. The award ensures continued, streamlined access for federal agencies and authorized purchasers to acquire EPI’s FDA-cleared Alpha-Stim® medical devices through pre-negotiated pricing and simplified
Learn More About Alpha-Stim
Learn more about Alpha-Stim AID and Alpha-Stim M today to discover a new way to treat anxiety and insomnia and relieve pain.